Please assess the completion status of the following clinical trial:

Trial Title: Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients planning to undergo HCT or other cellular therapy/immunotherapy~* Allogeneic related donors~* Aged 0-80~* Willing and able to sign voluntary written consent~Exclusion Criteria:~* Patients whose medical record indicates that they have opted out of research

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Immune and Microbial Reconstitution (Type: None): None
- Immune Response Triggered by Severe, Systemic Viral Infection (Type: None): None
- Immune Response Triggered by Acute Graft-versus-Host Disease (Type: None): None
- Immune Response Triggered by Chronic Graft-versus-Host Disease (Type: None): None
- Immune Response Triggered by Relapse (Type: None): None
- Immune Response Triggered by Cytokine Release Syndrome (Type: None): None
- Allogeneic Related Donor Samples (Type: None): None
- Cellular Therapy Products (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).